News

CyDex claimed that the new product is a premixed intravenous (IV) bag formulation of Prism Pharmaceuticals’ Nexterone injection, which was the first CyDex licensed proprietary product to achieve

As per the terms of the agreement, Boehringer Ingelheim will nominate up to seven targets, which may span multiple therapeutic areas, against which the parties will collaborate to

As per the terms of the agreement, Convergence Pharma will apply its ion channel biology platform, medicinal chemistry know-how and preclinical development expertise, recently formed out of GlaxoSmithKline

CTI said that in the current study, patients received PPX with TMZ and RT for six weeks and the main toxicity was grade 4 thrombocytopenia and neutropenia in

The minority shares are currently owned by University of Colorado (CU) chemists Lajos Gera and Robert Hodges (the minority shareholders) who have granted the sole and exclusive option

Syndeohealth claims that it continues to bring effective solutions to help physicians to reduce medical errors, make informed clinical decisions for their patients and improve the quality of

SuccessEHS said that its Mobile EHR is a convenient and portable way for physicians to review summary patient data and dictate into SuccessEHS EHR. SuccessEHS said that by

SDIS is a solution that closes a major gap in the nonclinical phase of the R&D lifecycle and also creates an instantly searchable resource of all nonclinical study

Antares claims that its new Vibex QS auto-injector platform offers a dose capacity of 1ml and greater in a compact design. Additionally, the new design also accommodates fast